Programmed in vivo excision of prophage {varphi}13 is an essential timing device for the Staphylococcus aureus infectious process
Mobile genetic elements play an essential part in the infectious process of major pathogens, yet the role of prophage dynamics in Staphylococcus aureus pathogenesis is still not well understood. Here we studied the impact of the {Phi}13 hlb- converting prophage, whose integration inactivates the hlb {beta}-toxin gene, on staphylococcal pathogenesis. We showed that prophage {Phi}13 is lost in approximately half the bacterial population during the course of infection. Inactivation of the {Phi}13 int recombinase gene, essential for insertion/excision, locked the prophage in the bacterial chromosome, leading to a significant loss of virulence in a murine systemic infection model. In contrast, the non-lysogen strain ({Delta}{Phi}13), where the hlb beta-hemolysin gene is reconstituted, displayed strongly increased virulence. Accordingly, histopathological analyses revealed more severe nephritis in mice infected with bacteria lacking prophage {Phi}13 ({Delta}{Phi}13), compared to infection with the parental strain. Infection with the {Delta}int mutant, where beta-hemolysin production is abolished, led to the least severe renal lesions. Cytokine induction in a human neutrophil model showed significantly increased IL-6 expression following infection with the beta-hemolysin producing strain ({Delta}{Phi}13). Our results indicate that timely in vivo excision of the {Phi}13 prophage is essential for progression of the Staphylococcus aureus infectious process: early excision leads to rapid host death whereas the inability to excise the prophage significantly reduces staphylococcal virulence. IMPORTANCEThis study highlights prophage {Phi}13 excision as a critical factor in S. aureus pathogenesis, influencing infection outcomes by balancing rapid host killing with reduced bacterial virulence. This mechanism may represent a bet-hedging strategy in genetic regulation, resulting in a mixed bacterial population capable of rapidly switching between two processes: bacterial colonization and host damage. Unraveling this dynamic opens new possibilities for developing targeted therapies to disrupt or modulate prophage activity, offering a novel approach to mitigating S. aureus infections.